Urine miRNA in nephrotic syndrome

Area of Science:

• Nephrology
• Molecular Biology
• Biomarker Discovery

Background:

• Nephrotic syndrome is a significant clinical nephrology issue, typically indicating glomerular disease with diverse causes.
• Kidney biopsy, the current standard for histological classification and monitoring, is invasive and carries risks.
• MicroRNAs (miRNAs) are regulatory molecules with altered urinary levels observed in nephrotic syndrome.

Purpose of the Study:

• To explore the potential of urinary miRNAs as non-invasive biomarkers for nephrotic syndrome diagnosis and monitoring.
• To review current evidence on specific urinary miRNA alterations in various nephrotic conditions.

Main Methods:

• Analysis of existing literature on urinary miRNA levels in nephrotic syndrome.
• Comparison of miRNA profiles across different etiological subtypes of nephrotic syndrome.

Main Results:

• Urinary miR-192 levels are lower in diabetic nephropathy.
• Urinary miR-200c levels are elevated in minimal change nephropathy and focal glomerulosclerosis.
• Elevated urinary miR-21, miR-216a, and miR-494 may predict renal function decline.
• Urinary miRNA targets show potential in lupus nephritis assessment.

Conclusions:

• Urinary miRNAs are stable and quantifiable, presenting a potential non-invasive diagnostic and monitoring tool for nephrotic syndrome.
• Current evidence is based on small-scale studies, necessitating larger research efforts for clinical validation.